Get the Stockscreener App
572.77
0.43%
-2.47
After Hours:
572.81
0.04
+0.01%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $572.77, with a volume of 1.86M.
It is down -0.43% in the last 24 hours and up +0.90% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$575.24
Open:
$578
24h Volume:
1.86M
Relative Volume:
0.92
Market Cap:
$215.19B
Revenue:
$43.74B
Net Income/Loss:
$6.58B
P/E Ratio:
33.09
EPS:
17.3072
Net Cash Flow:
$6.11B
1W Performance:
-3.06%
1M Performance:
+0.90%
6M Performance:
+43.78%
1Y Performance:
+9.97%
1-Day Range:
$569.62
$579.09
1-Week Range:
$560.16
$597.68
52-Week Range:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
572.77 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.25 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.10 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.49 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
225.85 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Michel Lagarde Sells 32,000 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Insider Selling: Thermo Fisher Scientific (NYSE:TMO) COO Sells 30,000 Shares of Stock - MarketBeat
Lagarde of Thermo Fisher sells $12.4m in stock - Investing.com
Lagarde of Thermo Fisher sells $12.4m in stock By Investing.com - Investing.com UK
Will Thermo Fisher's Asia Bioprocessing Tri-Hub Expansion Reshape Thermo Fisher Scientific's (TMO) Narrative? - simplywall.st
Thermo Fisher Scientific expands bioprocessing capabilities in India, Korea and Singapore - chemengonline.com
Regional expansion to accelerate Asian biopharma growth - Labmate Online
Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga
Knuff & Co LLC Sells 3,559 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stake Cut by Kennedy Capital Management LLC - MarketBeat
$1.22 Bn Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035: Growth Driven by Shift From Broad-Spectrum Treatments to Personalized Therapeutic Development - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. $TMO Shares Sold by Baird Financial Group Inc. - MarketBeat
Amundi Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Can Thermo Fisher Scientific Inc. (TN8) stock sustain double digit ROE2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
Thermo Fisher’s New Asia Bioprocessing Network Might Change The Case For Investing In Thermo Fisher Scientific (TMO) - Yahoo Finance
Thermo Fisher Scientific expands Bioprocess Design Centers to strengthen Asia’s biopharma manufacturing capacity - BioMelbourne Network
Insider Selling: Thermo Fisher Scientific (NYSE:TMO) EVP Sells 6,912 Shares of Stock - MarketBeat
Frederick Lowery Sells 6,913 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Thermo Fisher Scientific (TMO): Reassessing Valuation After Recent Share Price Gains - simplywall.st
BioNexus gets $500M to step into manufacturing; Thermo Fisher, AtomVie expand - Endpoints News
What Made Thermo Fisher Scientific (TMO) a Solid Performer in Q3? - Insider Monkey
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock gains from tech spendingJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - Newser
GENinCode Plc (AIM: GENI) up 33% on Thermo Fisher commercialisation deal - Share Talk
GENinCode surges on Thermo Fisher deal to roll out heart-disease test - Proactive Investors
GENinCode Partners with Thermo Fisher for CARDIO inCode-Score® Expansion - TipRanks
Thermo Fisher Scientific(TMO.US) Officer Sells US$8.15 Million in Common Stock - 富途牛牛
Thermo Fisher launches purpose-built next-gen triple quad mass spec - SelectScience
Jim Cramer Says He Feels “Particularly Good About” Thermo Fisher - Insider Monkey
Thermo Fisher Scientific Insider Sold Shares Worth $8,154,131, According to a Recent SEC Filing - marketscreener.com
Thermo Fisher Scientific (TMO) SVP & General Counsel reports Form 4 stock sale - Stock Titan
Thermo Fisher (TMO) EVP Lowery discloses December 2025 option exercises and share sales - Stock Titan
TMO (NYSE: TMO) insider Michel Lagarde files Form 144 to sell 32,000 shares - Stock Titan
TMO Stock Benefits From New Bioprocess Design Center in Asia - TradingView
Westerkirk Capital Inc. Buys Shares of 17,000 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Expands Bioprocessing Capabilities Across Asia - Contract Pharma
Groupe la Francaise Raises Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
New Bioprocess Design Center In Hyderabad Boosts Thermo Fisher’s Asian Bioprocessing Capabilities - Sahyadri Startups
India could scale semiconductor manufacturing faster than expected, says Thermo Fisher leaders - ET Manufacturing
Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers - BioSpectrum Asia
Thermo Fisher expands bioprocessing capabilities across Asia - Investing.com
Thermo Fisher expands bioprocessing capabilities across Asia By Investing.com - Investing.com India
Thermo Fisher (TMO) boosts Asia biopharma support with new and expanded design centers - Stock Titan
COO Lagarde Files To Sell 30,000 Of Thermo Fisher Scientific Inc [TMO] - TradingView
Thermo Fisher Scientific (TMO) insider files to sell 30,000 shares worth 17,457,611.41 - Stock Titan
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com
Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts - ts2.tech
Thermo Fisher Scientific (NYSE: TMO) insider plans sale of 6,912 shares - Stock Titan
Thermo Fisher Scientific Inc (TMO) Stock Forecasts - Yahoo Finance
Thermo Fisher Scientific Inc. $TMO Shares Bought by OMERS ADMINISTRATION Corp - MarketBeat
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $670 From $656, Keeps Overweight Rating - marketscreener.com
As the bio industry grows, Thermo Fisher Scientific (TMO), the world's No. 1 producer of life scienc.. - 매일경제
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):